IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/f6efe2b81ce1ebfb2e66ebaa511e8ead.pdf

Abstract Title

First Name *

Jonathan

Last Name *

Barratt

Co-author 1

Jürgen Flöge jfloege@ukaachen.de University Hospital, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Division of Nephrology Aachen

Co-author 2

Vishal Duggal duggal.vishal@gene.com Genentech, Inc. Clinical Science South San Francisco

Co-author 3

Nadine Schmit nadine.schmit@roche.com F. Hoffmann-La Roche Ltd PD Clinical Science Basel

Co-author 4

Ji Cheng emmy.cheng@roche.com Hoffmann-La Roche Ltd PD Data Sciences Mississauga

Co-author 5

Jeannette Lo lo.jeannette@gene.com Genentech, Inc. Translational Medicine South San Francisco

Co-author 6

Brad Rovin Brad.Rovin@osumc.edu The Ohio State University College of Medicine Department of Internal Medicine Columbus

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15